Biosyent Inc
XTSX:RX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biosyent Inc
XTSX:RX
|
CA |
|
Y
|
Yandex NV
F:YDX
|
NL |
|
ACS Actividades de Construccion y Servicios SA
MAD:ACS
|
ES |
|
Douglas Dynamics Inc
NYSE:PLOW
|
US |
|
Stylam Industries Ltd
NSE:STYLAMIND
|
IN |
|
S
|
Silicon Craft Technology PCL
SET:SICT
|
TH |
|
O
|
Orezone Gold Corp
TSX:ORE
|
CA |
Wall St Price Targets
RX Price Targets Summary
Biosyent Inc
According to Wall Street analysts, the average 1-year price target for RX is 16.83 CAD with a low forecast of 16.67 CAD and a high forecast of 17.33 CAD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RX's stock price target?
Price Target
16.83
CAD
According to Wall Street analysts, the average 1-year price target for RX is 16.83 CAD with a low forecast of 16.67 CAD and a high forecast of 17.33 CAD.
What is the Revenue forecast for Biosyent Inc?
Projected CAGR
26%
Over the last 14 years, the compound annual growth rate for Revenue has been 22%. The projected CAGR for the next 3 years is 26%.
What is the Operating Income forecast for Biosyent Inc?
Projected CAGR
-11%
Over the last 14 years, the compound annual growth rate for Operating Income has been 26%. The projected CAGR for the next 6 years is -11%.
What is the Net Income forecast for Biosyent Inc?
Projected CAGR
18%
Over the last 14 years, the compound annual growth rate for Net Income has been 24%. The projected CAGR for the next 3 years is 18%.
